Still having trouble finding Zepbound (Tirzepatide)? Still seeing shortages? What’s the issue with Lilly and Zepbound anyway?
You may have been following the ongoing Big Pharma drama surrounding Eli Lilly and Zepbound (Tirzepatide). Lilly holds patent rights to both Zepbound and Mounjaro, but here’s where things get interesting: when a medication like GLP-1s is listed on the FDA shortage list, compounding pharmacies can step in to produce it until the shortage is […]